Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in KRAS Wild-type Small Bowel or Ampulla of Vater Adenocarcinoma
NCT01202409Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2010
- Primary completion
- Jul 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in small bowel adenocarcinoma (SBA), ampulla of Vater adenocarcinoma, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2010; status: completed.
02
Drugs
panitumumab
03
Conditions
small bowel adenocarcinoma (SBA)ampulla of Vater adenocarcinoma
Beyond the preview
Go deeper on NCT01202409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202409.